Anna Malkina, MD

Nephrologist

Dr. Anna Malkina is a nephrologist who specializes in the diagnosis and management of acute and chronic kidney diseases, hypertension and kidney stones. She is passionate about patient education and engaging patients in self-care.

Malkina earned her medical degree from the University of California San Diego School of Medicine, where she was especially active in caring for patients at the Student-Run Free Clinic Project. She completed a residency in internal medicine and a fellowship in nephrology at UCSF.

An assistant clinical professor at UCSF, Malkina is interested in educating future physicians in the field of nephrology. She teaches in both the hospital and clinic settings. Her honors include the Arnold P. Gold Foundation Humanism in Medicine Award at UCSD and the Andy I. Choi M.D. Memorial Scholarship at UCSF.

Clinics

Nephrology and Hypertension Faculty Practice
400 Parnassus Ave., B1 Plaza Level
San Francisco, CA 94143-0532
Phone: (415) 353-2507
Fax: (415) 353-2530

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Internal Medicine, American Board of Internal Medicine

Academic Title

Assistant Professor

More about Anna Malkina

Additional Languages

Russian

Education

University of California at San Diego School of Medicine 2009

Residencies

UCSF Medical Center, Internal Medicine 2012

Fellowships

UCSF Medical Center, Nephrology 2014

Selected Research and Publications

  1. Malkina A, Tuot DS. Role of telehealth in renal replacement therapy education. Semin Dial. 2018 Mar; 31(2):129-134.
  2. Malkina A, Scherzer R, Shlipak MG, Bacchetti P, Tien PC, Grunfeld C, Kosmiski L, Peralta CA. The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study. HIV Med. 2015 Mar; 16(3):184-90.
  3. Malkina A, Katz R, Shlipak MG, Ix JH, de Boer IH, Sarnak MJ, Allison M, Kramer HJ, Lin J, Siscovick D, Peralta CA. Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m2: Results from the Multi-Ethnic Study of Atherosclerosis (MESA). Open J Endocr Metab Dis. 2013 May 23; 3(2):103-112.
  4. Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res. 2006 Apr 01; 66(7):3419-27.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.